AI and robotics investment trends in 2024 reflected a market divided between enthusiasm for artificial intelligence and pressure on more cyclical automation businesses. An annual report from Natixis International Funds (Lux) I offers one view of that divergence through the performance commentary for its Thematics AI and Robotics Fund. It is an investment perspective, not a measure of industrial technology adoption, but the segment-level results highlight conditions that automation engineers, integrators and operations leaders may want to keep in mind when assessing the market environment.
The fund returned 9.61% for its I/A (USD) share class in 2024, while the MSCI ACWI reference index returned 17.49%. The fund therefore recorded a positive absolute return but underperformed its benchmark. The report attributes the mixed result to differing conditions across portfolio segments: cyclical robotics holdings faced a muted macroeconomic environment and capital investment spending amid higher interest rates in most regions, while AI-related stocks generally performed better.
AI and robotics investment trends reveal a split market
The distinction between AI-related companies and robotics businesses matters because the two categories can respond to different market drivers. The report describes continued investment around generative AI and its diffusion through the economy and broader society as support for robust fundamentals in AI-related holdings. At the same time, higher rates and restrained capital spending created headwinds for more cyclical robotics holdings.
For industrial decision-makers, this is a useful reminder that broad enthusiasm for automation or AI does not necessarily translate into uniform financial results across every part of the value chain. Software, semiconductor, factory automation and medical automation companies may be exposed to different customer budgets, investment cycles and market expectations. The report does not assess plant-level deployment or quantify adoption; it describes portfolio performance and the factors identified by the fund manager.
Factory automation faced different conditions from AI-related holdings
Within the fund’s segment breakdown, Factory Automation and Medical Automation delivered negative returns during 2024. Supply Chain, Office Automation, Consumer Automation and Design software finished the year in positive territory. That contrast points to varied performance within a single thematic strategy rather than a uniform rise or fall across automation-related businesses.
The report links weaker results for cyclical robotics holdings to a subdued macroeconomic environment and capital investment spending, with higher rates in most regions. For manufacturers and system integrators, this context helps explain why sentiment around AI can remain strong even while investment conditions affecting some automation suppliers are less favorable. It does not, by itself, indicate whether a particular project is commercially or operationally justified: that assessment still depends on a facility’s requirements and investment criteria.
Performance also varied between individual holdings
At the individual holding level, the three largest detractors were AutoStore in Factory Automation, Tecan in Medical Automation and Symbotic in Factory Automation. The three largest contributors were Nvidia and TSMC, both categorized in Supply Chain, and Intuitive Surgical in Medical Automation.
These examples illustrate why segment labels alone do not explain a fund’s results. Medical Automation, for instance, included both a reported detractor and a contributor among the named holdings. The figures describe how those investments affected this fund over the period; they should not be read as a technical comparison of products, systems or operating outcomes.
What the results suggest for automation decision-makers
The report offers a market-level snapshot, not a buying guide for industrial equipment. Still, its account of 2024 conditions provides several practical points to consider when reviewing automation plans:
- Separate technology themes. AI-related software and semiconductors did not move in lockstep with factory and medical robotics holdings in the fund’s reporting.
- Account for investment-cycle conditions. The report identifies higher rates and muted capital spending as headwinds for cyclical robotics holdings. Such conditions can form part of the wider environment in which suppliers and customers make investment decisions.
- Look beyond broad categories. Results differed across segments and individual holdings, so a label such as “automation” does not tell the whole story.
- Distinguish market performance from operational evidence. Fund returns do not establish the performance, suitability or financial return of a specific automation system in a plant.
These points are most useful as context for discussions among engineering, finance and operations teams. Market commentary can help describe the investment climate, but project evaluation needs to remain grounded in the facility’s own requirements and decision process. The annual report does not provide project-level measures or recommendations for selecting automation technology.
Conclusion: interpret automation market signals with care
The 2024 results show a clear divergence within one AI and robotics investment strategy: AI-related holdings generally performed better, while factory and medical automation segments faced a more difficult year. Higher interest rates and muted capital investment spending were cited as pressures on cyclical robotics businesses, while ongoing investment around generative AI supported stronger fundamentals for AI-related stocks.
For industrial automation professionals, the central implication is not that one technology category is inherently preferable. Rather, market conditions and company exposure can vary substantially across the automation landscape. Use investment reports as background on sentiment and financial-market trends, while keeping technical and operational decisions tied to the specific needs of the application.